ABCG2 and skin neoplasm: This notion is in agreement with previous studies using skin cancer cell lines where enhancement of ALA-PDT response by ABCG2 transporter inhibitors was only observed in ABCG2-positive cells but not in ABCG2-negative cells26, 27, 28.